Therapnea Labs

Company Overview

Snapshot

Founded in January 2013 by Avi Lior and Noam Hadas, Therapnea Labs operates with 1–10 employees.

Business overview

Therapnea Labs is a MedTech company focused on developing a novel, patented technology to treat Obstructive Sleep Apnea (OSA). Their core product is a stent applied inside the patient's mouth from a dental plate, providing mechanical support to prevent upper airway collapse. The company serves the healthcare industry, specifically targeting patients with sleep disorders, and operates within the Medical Devices and Medical Treatment & Therapeutics sectors. They are also developing a device to prevent snoring using the same technology.

Company Intelligence Q&A

What is Therapnea Labs' primary focus?

Therapnea Labs is primarily focused on developing a patented medical device to treat Obstructive Sleep Apnea (OSA).

What is the core technology behind Therapnea Labs' solution?

Therapnea Labs utilizes a novel, patented technology involving a stent applied inside the patient's mouth from a dental plate, which provides mechanical support for the upper airways to prevent collapse. This method is designed to circumvent the gag reflex.

Has Therapnea Labs conducted any clinical studies?

Yes, Therapnea Labs has conducted a proof-of-concept clinical study. This study validated the device's ability to circumvent nausea and the gag reflex in 100% of patients and prevent apnea events after stent insertion.

Who are the founders of Therapnea Labs?

Therapnea Labs was founded by Avi Lior and Noam Hadas.

What is Therapnea Labs' funding status?

The company is currently in the Pre-Funding stage.